Financial comparisons BeOne Medicines Ltd.
Equities
ONC
US07725L1026
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
269.63 USD | -2.50% |
|
+5.38% | +45.97% |
12/06 | Sector Update: Health Care Stocks Lean Lower Premarket Thursday | MT |
12/06 | BeOne Medicines Ltd Showcases Breakthrough Data in CLL and MCL at EHA 2025 | CI |
Main competitors
Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
---|---|---|---|---|---|---|---|
381.02Cr | -16.92% | -14.91% | -18.77% | -11% | 4.06x | ||
1.42TCr | 31.07% | 36.33% | 19.23% | 15.02% | -1.12x | ||
221.87Cr | 36.99% | -0.96% | 2.26% | 2.02% | 234.49x | ||
537.62Cr | 24.08% | 29.51% | 16.78% | 12.27% | -0.97x | ||
284.82Cr | -24.18% | -47.77% | -3.3% | -2.88% | 9.36x | ||
36Cr | -251.24% | -241.47% | -1,601.19% | -54.47% | 0.16x | ||
255.86Cr | 17.97% | 25.37% | 11.65% | 8.43% | -0.66x | ||
298.83Cr | 36.44% | 32.53% | 22.97% | 19.34% | -2.97x | ||
216.87Cr | 24.04% | 27.88% | 23.13% | 17.7% | -1.75x | ||
29Cr | -24.22% | -26.28% | -8.94% | -4.69% | -2.82x | ||
26Cr | -13.8% | -7.18% | -9.46% | -9.11% | 3.86x | ||
4.19Cr | -410.18% | -365.73% | - | - | - | ||
63Cr | -28.22% | -21.76% | -15.45% | -10.06% | 13.02x | ||
18Cr | -258.64% | -276.39% | -80.35% | - | 1.63x | ||
30Cr | 30.46% | 17.83% | 7.52% | 6.63% | -9.98x | ||
49Cr | 40.03% | 45.91% | 30.74% | 24.08% | - | ||
87.03L | -1,720.87% | -2,029.33% | -21.13% | -18.79% | 6.29x | ||
Average | 227.84Cr | -147.48% | -165.67% | -101.52% | -0.37% | 16.84x | |
Weighted average by Cap. | 454.46Cr | -50.51% | -58.55% | -100.66% | 0.89% | 30.45x |
- Stock Market
- Equities
- ONC Stock
- Sector BeOne Medicines Ltd.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition